Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company seeking a Director, Business Growth and Enablement to lead capability building initiatives within the Development & Clinical Sciences organization.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Kyverna Therapeutics